MOLECULAR CELLULAR BIOLOGY, Sept. 1990, p. 4935-4941                                                                 Vol. 10,  9
0270-7306/90/094935-07$02.00/0
Copyright © 1990, American Society Microbiology


               SPT6, Essential Gene Affects Transcription                Saccharomyces cerevisiae, Encodes Nuclear Protein
                    Extremely Acidic Amino Terminus
                     MICHELE S. SWANSON,1'2 MARIAN CARLSON,2 FRED WINSTON'*
            Department Genetics, Harvard Medical School, Boston, Massachusetts 02115,1 Department                     Genetics Development Institute Cancer Research, Columbia University,
                             College Physicians Surgeons, New York, New York 100322
                                            Received 5 March 1990/Accepted 31 1990

             SPT6 essential gene Saccharomyces cerevisiae appears play role transcription. Mutations
           SPT6 (SSN20, CRE2) gene suppress 8 insertion mutations 5' regions HIS4 LYS2            mutations cis- trans-acting elements required expression SUC2 ADH2. report
           SPT6 encodes 170-kilodalton highly charged protein extremely acidic amino terminus.            use epitope-tagged SPT6 protein, determined indirect immunofluorescence SPIT6
           protein located nucleus.

   Mutations Saccharomyces cerevisiae gene SPT6                    highly charged 1,451-amino-acid protein 168,290 daltons
 called SSN20 [25, 26] CRE2 [7, 8])                    (Da). entire protein, 19 o residues acidic
isolated suppressors cis- trans-acting muta-               15  basic. striking characteristic pre-
tions alter transcription particular genes. Mutations          dicted protein acidic amino terminus: 70
SPT6 isolated suppressors insertion                   residues net charge -30 (50 o acidic residues), mutation HIS4 gene (his4-9128) caused long                    amino-terminal protein (484 residues) terminal repeat transposable element Ty (32). Domi-                net charge -81 (29  acidic residues). addition, nant recessive mutations SPT6 (called SSN20)                  SPT6 sequence included consensus sites phos- isolated extragenic suppressors defect SUC2             phorylation casein kinase II (20; reviewed reference 2;
expression caused snf2 snJ5 mutations shown                G. Prelich F. Winston, unpublished observations). act suppressors snf6 (26) SUC2 mutant alleles                  Acidic residues characteristic activation  upstream activation sequence deletions (25). spt6                mains yeast transcriptional activators GAL4 (21) mutation, called cre2-1, isolated selection                  GCN4 (16, 17).  negatively charged region mutations allow ADH2 escape glucose repression.                   SPT6 extensive acidic cre2-1 mutation restores moderate level ADH2                previously characterized transcription activation domains.
expression absence trans-acting positive acti-              Acidic regions proteins vator ADRI (7, 8). case examined,                  thought interact chromatin  reference 10 suppression spt6 mutations mediated level                 review).
transcription (6, 25).                                                      Data base searches (National Biomedical Research Foun-
   SPT6 gene cloned complementation                 dation Protein Sequence Database release 21 translated
spt6 ssn20 allele, 4.6-kiobase (kb) mRNA                 GenBank version 62) did reveal proteins significant
identified (6, 25). gene mapped right arm               sequence similarity SPT6.
chromosome VII (6, 25). Null alleles SPT6                       Identification SPT6 protein. identify SPT6
structed lethal haploid cells (6, 25),
consistent temperature-sensitive lethality conferred             protein, prepared specific antibody. trpE-SPT6 spt6 alleles (7, 26, 32). Experiments cloned             gene fusion, encoding SPT6 residues 474 860, 
SPT6 gene demonstrated increased decreased                 structed cloning restriction fragment SPT6 dosage wild-type SPT6 gene suppresses his4-9128               pATH11 vector (gift T. J. Koemer, J. Hill, 
mutations (6) SUC2 upstream regulatory region dele-                   Tzagoloff) create plasmid pMS1. TrpE-SPT6 hybrid
tions (25). results suggested SPT6 protein                 protein expressed Escherichia coli HB101 (3), puri-
functions complex affected altered               fied method Kleid et al. (19), used immunize
stoichiometry (6, 25). SPT6 appears play essen-               rabbits. SPT6-specific antibody purified tial general role transcription, characterized             serum rabbit chromatography Protein Seph- gene product.                                         arose CL-4B (Pharmacia), followed affinity chromatogra-
   Sequence SPT6 gene. nucleotide sequence              phy TrpE-SPT6 protein coupled CNBr-activated
SPT6 gene determined method Sanger et al.                   Sepharose (Pharmacia) adsorbent according 
(30). open reading frame (Fig. 1) extended 4353 base              structions supplied manufacturer. TrpE-SPT6
pairs, size consistent 4.6-kb SPT6 RNA identified              hybrid protein used prepare column purified previously (6, 25). nucleotide sequence predicted                   described Bhown Bennett (1).
                                                                             SPT6 protein identified immunoblot analysis
                                                                          total yeast proteins. protein detected approxi-
                                                                          mately 170 kDa, size predicted SPT6 DNA
  *
      Corresponding author.                                               sequence.  170-kDa protein abun-
                                                                   4935
 4936      NOTES                                                                                                               MOL. CELL. BIOL.

       -396                                      AGCTGACTGATTCTTTATAGCAATAGGGAGGAAGGCAGTACACATATCAGCAGTGCATGGGCACAACCCGCATTACA
       -321       ACGAACATGATATATCTATATAAGAAGATACGGACAGGCGGTCGAGGCTATTACTGTGCCACTATGCGAGTCATGAATGATTTTTAAAwTTAGTTAGTACCCCrT
       -214       TATATAACGTCTTCAATAAAAGTGCGGGMAAATTCGGGTAATA'TTTCTATAACTGTCATTTTTTTT, TCGTTATGTATGGCAACCAATTGACAAGAACTGGACA
       -107       ACGGTTAAAGCAAAGGAGGAAGAAGATATTGATTGTGCTTGAAGAATAACCCAAGCGAACAGGTCATTAATTGCCTAGAATCTTACATAGAATTGCCTTTT
              1   ATG GA GAG ACG GGA GAT TCG AAG CTG GTC CCT AGG GAC GAG GAA GAA ATA GTA AAT GAC AAC GAT GAA ACT AAGCG CCT
                  t :l-u Gl-u Thr Gly &-M S-r Lys Lou Val Pro Arg &o W:1 ";1 "; Ile Val &mAn &Gl       Thr Lys Ain Pro              27

          82      AGT GAG GAA GAA GAA GGA GAA GAT GTC TT GAC TCC TCT GAG GAA GAC GAA GAT ATT GAT GAA GAC GAA GAT GAG GCA AGA
                  S-r                        :  Val Phe &MS-r S-r fl-u Glu  G:l &sp Ile &-& f:l&-aa:1
                                      Gly 1GGI                                                          Aso&-      Ala Arg          S4

         163      AAA GTG CAA GAA GGC TTC ATT GTC AAC GAT GAT GAT GAA AAT GAA GAC CCA GGA ACA AGT ATT TCC AAA AAA AGA AGAAA
                  Lys Val Gin C:l Gly Ph- Ile Val Asn 1A=&W XAn Glu&- Pro Gly Thr Ser Ile Ser Lys Lys Arg Arg Lys                       el

         244      CAT AAA AGA AGA GAA AGA GAA GAA GAT GAT CGA CTA TCC GAA GAT GAT TTG GAT TTG TTA ATG GAG AAT GCT GGT GTT GAA
                  H isLys Arg Arg C Arg G" Q            Arg Lou Ser " &      = SQLou &  Lou Lou Meot G Asn Ala G ly Val             10

         325      CGT ACC AAGCG AGC TCC TCT TCA GGA AAA TT     AAA AGA TTA AAG AGA GTA GGA GAT GAA GGA AAC GCT GCA GAA TCA GAA
                  Arg Thr Lys Alm Ser Ser Ser Ser Gly Lys Phe Lys Arg Lou Lys Arg Val Gly &m    Ja" Gly Asn Ala Ala t:l Ser ":l           135

         40B      AGT GAC AAC GTC GCT GCA TCA AGG CAA GAT TCT ACG TCT AAA TTG GAA GAT TTC TTT TCT GAA GAT GAA GAA GAA GAA GAA
                  Sor & Asn Val Ain Ala Ser Arg Gln &-M Ser Thr Ser Lys Lou G;1  aQ Phe Phe Ser "u &m "u u s  "                   162

         487      TCT GGT TTA CGC AAC GGT AGG AAC AAT GAA TAT GGG CGT GAT GAA GAA GAC CAT GAA AAT AGG AAC AGA ACA GCT GAC AA
                  Ser Gly Lou Arg n Gly Arg Asn Asn "l Tyr Gly Arg &-M 01.u C:l&-W "l Asn Arg Asn Arg Thr Ala - Lys                 189

         588      GGT GGA ATC TTG GAC GAA TTG GAT GAT TTC ATT GAA GAT GAT GAA TT TCT GAT GAG GAC GAC GAA ACC AGA CAA AGG AGG
                  G ly G ly le Lou &W"Lou       Phe * Iu = G " Phe S-r &- 91 &apG  Iu Thr Arg G Arg Arg                218

         649      ATC CAA GAA AAG AAG CTT TTA AGA GAA CAA TCC ATC AACAA CCT ACA CAG ATT ACT GGT CTA TCG TCG GAT AAG ATT GAC
                  Ile-Giln G " Lys Lys Leu Lou Arg ": G ln Ser le Lys Giln Pro Thr G ln IleoThr G ly Lou Ser Ser pLys le &-         243

         730      GAG ATG TAT GAC ATT TTT GGT GAT GGT CAT GAC TAC GAT TGG GCT TTA GAA ATT GAA AAT GAA GAA CTA GAA AAT GGT AAC
                   "; Meot Tyr pIle Phe Gly A5Q Gly qTyr eTrp Ala Lou "l Ile "l Asn G1 " Lou Gl Asn Gly Asn                     270

         811      GAC AAC AAT GAA GCT GAA GAA GAA GAG ATC GAT GAA GAA ACT GGT GCT ATA AAAGC ACC AAG AA AG ATA TCT CTA CAA
                  Asp Asn Asn G1 Ala Glu Glu " G11 Ile &-W Glu G:l Thr Gly Ala Ile Lys Ser Thr Lys Lys Lys Ile Ser Lou Gln                297

         892      GAC ATT TAT GAT TTA GAG GAT TTG       AAC TTG ATG ACT GAA GGA GAC ATG AAA ATT AGA MaA ACA GAT ATT CCA G
                    apIleoTyr Lou G     u Leu Lys Lys   Asn Lou Met Thr G GlIy  Met Lys IlIe Arg Lys Thr pI le Pro G        1   324

         973      AGA TAT CAA GAA TTA AGA GCA GGT ATT ACT GAC TAC GGA AAT ATG TCA TCG GAG GAT CA GAA TTA GAA AGA AAC TGG ATA
                          Gln "Leu Arg Ala Gly Ile Thr  apTyr Gly Asn M-et Ser Ser Glu      Gin ALu Leu Glu Arg Asn Trp Ile             351
                  Arg Tyr
        1054      GCA GAAAA ATT TCT GTG GAT AAG AAC TTC GAT GCC AAT TAT GAT CTC ACT GAAMmAAM GAA GCA ATT GGG AAC GCA ATC
                  Ala Glu Lys Ile Ser Val & Lys Asn Phe Ala Asn Tyr Lou Thr GlU Phe Lys  Ala Ile Gly Ala Ile                   378

        '1135     AA     TTT ATC ACC AAGAA AAC TTG GAA GTC CCT TT ATA TAT OCT TAC CGT CGT AAC TAT ATT TCC TCA AGA GAAAA GAT
                                               Lou Glu Val Pro Phe Ile Tyr Ala Tyr Arg Arg Asn Tyr Ile S-r S-r Arg =Lys-S               405
                  Lys Ph- Ile Thr Lys Glu Asn
        1215      GGG TTT CTT TTG ACT GAA GAT GAC CTT TGG GAT ATA GTT AGC CTT GAC ATC GAA TT CAC AGT CTT GTG AAC AA AG GAT
                  G ly Phe Leu Lou Thr Q  - Lou Trp  le ValI S-r Leu AMIl e G | Phe H Ser Lou ValI Asn Lys Ly>s                432

        1297      TAT GTC CAG AGA TTT TAT GCA GAA TTA CAT ATC GAT GAT CCT ATT GTC ACT GAA TAC TTC AA CAG AAT ACT GCA TCT
                          Gln Arg Phe Tyr Ala "; Lou Ile MA       Pro Ile Val Thr {;11Tyr Phe Lys Asn Gin Aen Thr Ala S-r             4S9
                  Tyr Val
        1378      ATT GCG GAA CTG AAT TCT CTA CAG GAT ATT TAT GAC TAC CTA GAA TTC AAA TAT GCC AAC GAA ATC AAT GAA ATG TT ATA
                  Ile Ala G;1 Lou Ser Lou Gln AMIle Tyr Asa Tyr Lau aWPhe Lys Tyr Alm sn 1=. Ile 1= Met Ph* Ile                     486

        1459      AAC CAC ACT GGA AAG ACT GGT oAAAA CAT TTG AA TCC AGT TAT GAA AAmT         GCT AGT CCT CTT TAT CAA OcG
                  Thr  Gly Lys Thr Gly Lys Lys Lou Lys Asn S-r S-r Tyr SX1 Lys Phe Lys Ala Ser Pro Lou Tyr Gin Ala             513

         IE840    GTT AGT GAT ATT GGT ATA TCA GCT GAG GAT GTT GGT GAA AAT ATC AGT TCC CAG cAT CAA ATC CAC CCT CCC GTA GAT CAT
                                                          Val Gly aGu Asn Ile Ser Ser Gin Gin Ile Pro Pro Val               540
                  Val S-r  Ile Gly Ile Ser Ala Gl 
         1821      CCA AGT TCC AACCA GTA GACTG ATA GAA TCT ATA TTG AAT GCA AAC AGC aaT GAT TTG CAA GTC Tm ACG TCC AAT ACT
                                                                                                                      Thr                 S87
                   Pro S-r S-r Lys Pro Val aWVal Ile al S-r Ile Lou Asn Ala Asn S-r Gly Lou GIn Val Ph- Thr S-r Asn

         1702      AAG CTG GCA ATT GAT ACG GTC CAA AAA TAC TAC TCT TTG GAA TTG TCT AAA AAT ACA AAA ATA AGG GAA AAA GTT AGA S-r
                                                                                                                           TCC
                                                                                                                                          S94
                   Lys Lou laI le
                                    -
                                       Thr Va G Lys Tyr Tyr Ser Lou S;1 Lou Ser Lys Thr Lys Ile-Arg  Lys ValI Arg

         1783      GAT TTT TCC AATAT TAT CTG GCT GAC GTT GTG TTA ACT OCT AAA GGT AAAAA          ATT CAA AAG    GAaTCT CTG TAT GAG
                                                                                                                                          621
                    Phe Ser Lys Tyr Tyr Leu Alasa Val Val Lou Thr Ain Lys Gly Lys Lys Q"Ile Gin Lys Gly S-r Lou Tyr u
         1884      GAC ATA AATAT GCC ATC AAT AGA ACT CCA ATG CAC TTC CGT AGG GAT CCA GAC GTT TTT|TTGAA          ATG GTC GAG GCT aGA
                                                                                                                      Ala Glu         848
                    Ile Lys Tyr Ala Ile Asn Arg Thr Pro t Phe Arg Arg AaPro fta VOI Phe Lou Lys MIet Val Glu
         1945      TCT TTG AAC CTG CTC AGT GTT AAG TTA CAC ATG TCG TCA CAA GCC CAA TAT ATA GAG CAT TTA TTC CAA ATT GCA CTT      GAA
                   Ser Lou Asn Leu Leu Ser Val Lys Leu hlet Ser Ser Gln Ala Gin Tyr Ile Q1lu Lou Phe Gin Ile Ala Lou    G1        675

         2025      ACT ACC AAT ACC TCG GAC ATC GCA ATA GAA TGG AAT AAC TTC CGT AACTG GCA TTC AAC CAA GCG ATG GAC AAG ATT TTC              702
                                                                                                                     Ile Phe
                   Thr Thr Asn Thr Ser &sp Ile Ala Ile ";1Trp Asn Asn Phe Arg Lys Leu Ala Phe Asn Gln Ala Met Lys

         2107      CAG GAT ATA TCT CAM GM GTC GAC AAT TTA ACA MT TGT CM TTG GTA GCC MG ACT GTT CGC CAT MG TTT
                   Gin Ilo Ser Gln G;lu Val Lys La- Asn Leu Thr Lys Asn Cys Gin Lys Lou Val Ala Lys Thr Val Arg Lys Phe             729
 VOL. 10, 1990                                                                                                          NOTES         4937

      2188   ATG ACA AAA TTA GAC CAG GCT CCA TTC ATT CCT AAT GTC AGG GAT CCA AAA ATT CCA AAA ATC TTA TCT TTA ACC TGT GGA
             Met Thr Lys Leu  GIn Ala Pro Ph. IIe Pro Asn Val Arg - Pro Lys IIe Pro Lys Ile Lou Ser Lou Thr Cys Gly    756

      2269   CAG GGT AGA TTC GGA GCC GAC GCT ATA ATT GCT GTC TAC GTC AAC AGA AAG GGT GAT TTT ATA AGA GAT TAC AAG ATT GTC
             Gln Gly Arg Phe Gly Ala Aa= Ala Ile Ile Ala Val Tyr Val Asn Arg Lys Gly nA Ph. Ile Arg Ama Tyr Lys Ile Val       783

      2350   GAC AAT CCA TTT GAT AAG ACG AAT CCT GAA AAA TTT GAA GAC ACC TTG GAT AAT ATC ATT CAA AGC TGT CAA CCG AAT GCC
              Asn Pro Ph.  Lys Thr Asn Pro G Lys Ph. QLLL Aa= Thr Lou Asn Ile Ile Gin S-r Cys GIn Pro Asn Ala      810

      2431   ATC GGA ATC AAT GGC CCT AAC CCA AAG ACT CAA AAA TTT TAC AAA AGA TTA CAA GAA GTT CTA CAT AAG   AAG CAA ATC GTC
             Ile Gly Ile Asn Gly Pro Asn Pro Lys Thr Gin Lys Phe Tyr Lys Arg Leu Gln Glu Val Lou Lys   Lys Gin Ile Val    837
                                                                                                EoBI
      2512   GAC AGT AGA GGA CAT ACT ATT CCA ATC ATT TAC GTT GAG GAC GAA GTC GCT ATC CGT TAT CAG AAT TCC   GAA AGA GCT GCT
             Ser Arg Gly Thr Ile Pro Ile Ile Tyr Val Glu lu Val Al Ile Arg Tyr Gin Asn Sor      G   Arg Ala Ala    864

      2593   CAA GAA TTC CCT AAT AAA CCT CCT CTA GTT AAA TAC TGT ATC GCC TTG GCG CGC TAT ATG CAT TCC CCA TTG TTG GAA TAT
             Gin G.L Ph. Pro Asn Lys Pro Pro Leu Val Lys Tyr Cys Ile Ala Leu Al. Arg Tyr Met Sor Pro Lou Lou aL Tyr       891

      2674   GCT AAT TTA ACA AGT GAA GAA GTG AGA TCA TTG TCA ATT CAT CCA CAC CAA AAT CTG TTA TCC TCA GAA CAA TTG AGT TGG
             Ala Asn Leu Thr Sor GJI u GI u Val Arg Sor Lou Sor Ile Pro Gin Asn Leu Leu Sor Sor GIn Leu Ser Trp   918

      2755   GCT CTT GAA ACC GCT TTC GTT GAT ATT GTC AAC CTG GTA AGT GTT GAA GTT AAC AAA GCC ACA GAT AAT AAT TAC TAC GCT
             Al. Lou Gl Thr Ala Phe Val M Ile Val Asn Lou Val Sor Val Glu Val Asn Lys Al. Thr  Asn Asn Tyr Tyr Al.        945

      2836   AGT GCG CTG AAA TAC ATC TCT GGC TTT GGA AAA CGT AAA GCT ATT GAT TTC TTA CAG TCC CTT CAA AGG CTA AAT GAA CCA
             Sor Ala Lou Lys Tyr Ile Sor Gly Ph. Gly Lys Arg Lys Al. Ile AMa Ph. Lou Gln Ser Lou Gin Arg Leu Asn  Pro       972

      2917   TTA CTG GCT CGT CAA CAA TTA ATT ACT CAT AAC ATT CTT CAC AAG ACT ATT TTT ATG AAT TCC GCG GGA TTC CTC TAT ATC
             Lou Lou Ala Arg Gln Gin Leu Ile Thr Asn Ile Leu Lys Thr Ile Ph. Mot Asn Sor Al Gly Ph. Leu Tyr Ile       999

      2998   TCA TGO AAT GAA AAA AGA CAA AAA TAC GAA GAT TTG GAA CAT GAT CAA CTA GAT AGC ACT AGA ATT CAT CCA GAA GAC TAC
             Ser Trp Asn .u Lys Arg Gln Lys Tyr GL&u Aa Leu G u Gln Lou Ama Sor Thr Arg Ile Pro GLu  Tyr         1026

      3079   CAT TTG GCC ACC AAG GTT GCC GCT GAT GCT TTA GAA TAC GAT CCT GAT ACT ATT GCC GAA AAA GAA GAA CAG GGG ACT ATG
             Leu Ala Thr Lys Val Ala Al. aa Ala Leu Gliu Tyr Pro Thr Ile Ala G.UL Lys G1IU G:L& Gin Gly Thr Met    1053

      3160   AGT GAA TTC ATT GAA CTG TTG AGA GAA GAT CCT GAC CGT AGA GCT AAA CTA GAA TCA CTA AAT CTA GAA TCA TAC GCA GAA
             Ser L Ph. Ile lu Lu Leu Arg G1L Pro  Arg Arg Ala Lys Lou GL Sor Lou Asn Lou Glu Ser Tyr Ala Gl.u            1080

      3241   GAA CTT GAG AAG AAT ACC GGA TTA AGA AAA CTT AAT AAT CTA AAT ACA ATT GTC CTT GAA TTG TTG GAT GGA TTT GAA GAA
             Glu Leu GlLu Lys Asn Thr Gly Leu Arg Lys Leu Asn Asn Leu Asn Thr Ile Val Lou Glu Leu Lou Gly Phe Gl.u Glu    1107

      3322   TTG AGA AAT GAC TTT CAT CCT TTG CAA GGT GAT GAA ATT TTC CAA AGT TTG ACT GGT GAG TCT GAA AAG ACG TTT TTC AAG
             Lou Arg Asn Ama Ph. Pro Leu Gin Gly  Glu Ile Ph. Gin Ser Leu Thr Gly Giu Ser Glu Lys Thr Ph. Ph. Lys      1134

      3403   GGT AGT ATT ATT CCA GTC AGA GTA GAA AGA TTC TGG CAC AAC GAT ATA ATT TGC ACT ACA AAC TCT GAA GTT GAA TGT GTA
             Gly Sor Ile Ile Pro Val Arg Val G Arg Ph. Trp Asn Ama Ile Ile Cys Thr Thr Asn Sor Gj" Val G.Lu Cys Val       1161

      3484   GTA AAT GCT CAA CGT CAC GCA GGT GCA CAA TTA AGA AGA CCT GCA AAT GAA ATA TAC GAA ATT GGT AAA ACA TAT CCA GCA
             Val Asn Al. Gin Arg Ala Gly Al. Gln Lou Arg Arg Pro Al. Asn Otlu Ile Tyr Gli Ile Gly Lys Thr Tyr Pro Ala     1188

      3565   AAG GTG ATA TAT ATT GAC TAT GCT AAT ATT ACT GCA GAA GTT TCC TTA TTA GAT CAT GAT GTC AAA CAG CAA TAT GTT CCA
             Lys Val Ile Tyr Ile Tyr Al. Asn Ilo Thr Al Glu Val Sor Leu Lou Aa AmVal Lys Gln Gln Tyr Val Pro           1215

      3646   ATA AGC TAC AGT AAA GAT CCT TCC ATT TGG GAC TTG AAA CAA GAA CTG GAA GAT GCC GAA GAG GAG AGG AAA TTG ATG ATG
             Ilo Sor Tyr Sor Lys  Pro Sor Ile Trp Aa Lou Lys GIn Giu Lou O;1 Ama Ala j      "   ji Arg Lys Lou Met Met      1242

      3727   GCA GAA GCC CGT GCA AAG AGA ACA CAT CGT GTT ATC AAT CAT CCT TAC TAT TTC CCT TTC AAC GOC AGA CAG GCT GAG GAT
             Al.  "iu Ala Arg Al. Lys Arg Thr Arg Val Asn Pro Tyr Tyr Phe Pro Pho Asn Gly Arg Gin Ala Gl       1269

      3808   TAC TTA AGG AGT AAA GAA CGT GOT GAA TTC GTG ATC AGA CAG TCT AOC CGA GGT GAT GAC CAC TTG GTT ATC ACC TGG AAA
             Tyr Lou Arg Sor Lys GILL Arg Gly ¢  Pho Val Ile Arg Gln Sor Ser Arg Gly As Lou Val Ile Thr Trp Lys        1296

      3889   TTG GAT AAG GAT TTG TTT CAA CAT ATT GAT ATC CAA GAA TTA GAA AAA GAA AAT CCT TTG GCT TTA GOT AAA GTC TTG ATT
             Lou Aa Lys Lou Phe Gin IIe Asa IIe GIn GIu Lou Guts Lys G1.U Asn Pro Lou Al. Lou Gly Lys Va. Leu IIe      1323

      3970   GTC GAC AAT CAG AAA TAC AAT GAT TTA GAC CAG ATC ATT GTA GAA TAT CTT CAA AAC AAG GTA AGG CTC TTG AAT GAA ATG
             Val AMa Asn Gin Lys Tyr Asn Ama Lou Asp Gin Ile Ile Val G"u Tyr Leu Gln Asn Lys Val Arg Leu Lou Asn Gus Mot      1350

      4051   ACA TCT AGT GAA AAA TTC AAA AGC GGT ACT AAG AAA GAT GTG GTC AAG TTT ATT GAA GAC TAC TCT AGA GTG AAT CCA AAT
             Thr Sor Sor Gus Lys Ph. Lys Sor Gly Thr Lys Lys Val Val Lys Ph. Ile G    Aa Tyr Sor Arg Val Asn Pro Asn       1377

      4132   AAG TCT GTG TAC TAT TTC AGT TTG AAC CAC GAT AAC CCT GGT TGG TTT TAC TTG ATG TTC AAG ATT AAC GCA AAT AGC AA
             Lys Sor Val Tyr Tyr Ph. Sor Lou Asn Asn Pro Gly Trp Pho Tyr Lou Mot Phe Lys Ile Asn Ala Asn Sor Lys       1404

      4213   TTA TAC ACA TGG AAT GTG AAA TTA ACG AAC ACT GGT TAT TTC CTG GTA AAC TAC AAT TAT CCA AGT GTT ATC CAG CTT TGT
             Leu Tyr Thr Trp Asn Val Lys Lou Thr Asn Thr Gly Tyr Phe Leu Val Asn Tyr Asn Tyr Pro Sor Val Ile Gin Lou Cys      1431

      4294   AAT GGT TTT AAG ACG CTT CTA AAA TCT AAC AGT AGT AAG AAT AGA ATG AAC AAC TAC CGT TAG ATGCGTATGTAGTGTCCATTGTT
             Asn Gly Pho Lys Thr Leu Lou Lys Sor Asn Ser Ser Lys Asn Arg Mot Asn Asn Tyr Arg ***                              1451

      4380   ATTATTAATTTTATTATTACTTTGACCATTGTTTAGGTAAGGTATGTAAACTAGAACGCTTCAACTGTATTTTTTACGTAATTATTTGCTGCATGTTTAGTTTCGCA
      4487   AAGTTTGTACCGTGACGAACATAGCACGAACACAACATTTAAGAATAGCTTGGGAACCAAAATTTAGAAATTTTTTTCACTAATGAGGGGCGTTGCAA
      4594   AGTGGCGACTATTTITGGTTCTTCAAATATTTGCAGGAAATAAATAATTTACTGTGCATTTCTGATTACATTTAGGATGTAAATTGACTTAGTAGACGTTCCA
 4938     NOTES                                                                                                                 MOL. CELL. BIOL.

   FIG. 1. Nucleotide sequence SPT6 gene (GenBank accession number M34391) predicted amino acid sequence gene
product. Nucleotides numbered left. Amino acids numbered right. Asterisks indicate termination codon. Acidic
residues underlined. EcoRI restriction sites used construct trpE-SPT6 gene fusion used antibody preparation indicated.
Additional EcoRI sites located positions 1389, 2596, 2973, 3059, 3163, 3832. HindlIl site used construct null mutation (6) position 661. complete sequence determined strands M13mpl8 M13mpl9 vectors (27). cases restriction fragments digested Bal3l nuclease (IBI) prior cloning, cases 20-base oligomers (Biopolymers Laboratory,
Department Genetics, Harvard Medical School) complementary adjacent SPT6 sequence used primers.


dant yeast cells carrying SPT6 gene multicopy                codon, initiation codon, 27 nucleotides encoding plasmid (Fig. 2, compare lanes B).                                 HAl epitope, 22 nucleotides 3' SPT6
  Nuclear localization SPT6 protein. distribution             initiation codon. mutated 1.8-kb HindIII fragment SPT6 protein yeast cells determined indirect            used create pMS33, encodes HAl epitope fused
immunofluorescence microscopy. Initially, attempted                complete SPT6 protein centromere-containing
localize SPT6 protein using affinity-purified SPT6-           plasmid. hybrid protein functional, judged specific antibody. antibody stained cells faintly                   ability complement temperature-sensitive lethality cell (data shown).                 Spt- phenotype caused spt6-140 mutation (32) (data
spt6 null mutation lethal (6, 25), yeast strain lacking             shown).
SPT6 protein available control determine                    study HA1-SPT6 hybrid protein, used specific staining nonspecific binding               monoclonal antibody HAl epitope, called
antibody.                                                                12CA5, prepared characterized previously (27).
   circumvent problem, used epitope addition               specificity anti-HAl antibody HA1-SPT6
method (12, 23). hybrid gene encoding antigenic                     hybrid protein yeast cells determined immu-
epitope hemagglutinin influenza virus (HAl [12,              noblot analysis. epitope-tagged SPT6 protein detected
27]) fused SPT6 protein constructed using              HAl-specific antibody (Fig. 2, lane C) comigrated
Muta-Gene M13 vitro mutagenesis kit (Bio-Rad Labora-                  wild-type 170-kDa SPT6 protein detected SPT6-
tories). template mutagenesis pMS26,               specific antibodies (Fig. 2, lanes B). staining contains 1.8-kb HindlIl fragment pCC11 (6) cloned               anti-HAl antibody observed strain lacking HAl HindIII site M13mpl9 (28). primer used               epitope (Fig. 2, lane D). mutagenesis 69-base oligonucleotide (Biopolymers                  determine cellular location SPT6 protein,
Laboratory, Department Genetics, Harvard Medical                      tetraploid cells (Table 1), large size facilitated micro-
School) including 17 nucleotides 5' SPT6 initiation           scopic analysis, prepared immunofluorescence mi-
                                                                         croscopy. Experiments HAl-specific antibody                                                                          strain containing HA1-SPT6 fusion protein demon-
                                 AB C D                                  strated epitope-tagged SPT6 protein located                                                                          nucleus cells, evident coincident fluores-
                                                                         cein DAPI (4',6'-diamidino-2-phenylindole dihydrochlo-
                         205-                                            ride) staining (Fig. 3A F). control experiment,                                                                          staining detected cells lacking HAl epitope (Fig.
                                                                         3G . HA1-SPT6 fusion protein provided SPT6
                          116-     t                                     function, likely wild-type SPT6 protein                           97-                                            located nucleus.
                                                                            address possibility HAl epitope itself
                          66-                                            directs proteins nucleus, determined cellular
                                                                         location HA1 galactosidase fusion protein. Previous

                          45-                                                                    TABLE 1. Yeast strains
                                                                             Strain                               Genotype'
  FIG. 2. Immunoblot analysis SPT6 protein. Total protein          MCRY1093        MATa his4-539 lys2-801 ura3-52
(40 ,ug lanes B 25 ,ug lanes C D) prepared        MCRY237         MATa his4-539 ura3-52 ssn20-1 [pCE204] described previously (4), separated electrophoresis 7.5 
polyacrylamide, electroblotted nitrocellulose. Protein sam-        MS146           MATa his4-9128 Iys2-1288 ura3-52 trplA63 [pCCl1]
ples prepared (lane  wild-type yeast strain MCRY1093,         MS147           MATa his4-9128 Iys2-1288 ura3-52 trplA63 [pMS33]
(lane B) spt6 mutant strain carrying SPT6 multicopy plasmid       MS149           MATalMATa ura3-521ura3-52 his4-91281his4-9128
(MCRY237), (lane C) wild-type yeast cells carrying HAI-SPT6                             Iys2-12881/ys2-1288 leu2Al/+ trplA631+ [pMS33]
hybrid gene centromere-containing plasmid (MS147), (lane         MS150           MATa/MATa ura3-521ura3-52 his4-91281his4-9126
D) wild-type yeast cells carrying SPT6 gene centromere-                            lys2-1288/1ys2-1288 leu2Al/+ trplA631+spt6-1401+
containing plasmid (MS146). SPT6-specific antibody affinity-purified      MS148           MS149 x MS150 rabbit diluted 1:20 used Promega Protoblot          BM330           MATTalMATa ura3-521ura3-52 his4-91281his4-9128 1:7,500 dilution rabbit immunoglobulin G (IgG)-                              Iys2-128811ys2-1288 trplA631trplA63
specific antibody affinity-purified goat serum conjugated     BM331           MATa/MATa ura3-521ura3-52 his4-91281his4-9128
alkaline phosphatase (lanes B). HAl-specific antibody                             lys2-12881/ys2-1288 trplA631trplA63
diluted 1:100 used 1:7,500 dilution mouse IgG-specific      BM339           BM330 x BM331
antibody affinity-purified goat serum conjugated alkaline     MS157           BM339 [pMS35]
phosphatase (lanes C D). minor bands lane B                                                                                           Plasmids indicated brackets. Diploid strains homozygous consistently presumably degradation products. Num-          MAT locus generated UV-irradiating diploid cells (300 ergs/mm2) bers right mark positions protein standards  kilodaltons).       screening diploids mate.
                                       {. 


                       f 
                       
                            va* _sS.^-:.
                            -M-




                                  *




                                  _t
                                      >
                                          :




                                              -vi
                                                        .: ::.':



                                                        ...




                                                              ..


                                                              ,$
                                                                   
                                                                        ::




                                                                             ,.




                     0.




                                      Xr ~          ~




  FIG. 3. Nuclear localization SPT6 protein indirect immunofluorescence. tetraploid yeast strain containing HA1-SPT6 fusion
protein (MS148)  F) congenic control strain lacking HAl epitope (BM339) (G  prepared essentially described Kilmartin Adams (18), cell cultures fixed 4  paraformaldehyde (Fisher). cells stained HAl-specific
antibody diluted 1:400 affinity-purified mouse IgG-specific F(ab')2 fragment conjugated fluorescein diluted 1:2,000. Micrographs shown phase contrast   D, G), fluorescein fluorescence (B, E, H), DAPI fluorescence, indicates DNA (C, F, . Cells examined Zeiss Photomicroscope III equipped epi-illumination fluorescence Zeiss Neofluar 63 x lens, N  1.25. Cells photographed Kodak TMAX-400 film. Exposure times 40 s used immunofluorescence micrographs experimental control samples. Bar, 5 ,um.
                                                                                  4939
 4940     NOTES                                                                                                         MOL. CELL. BIOL.




  FIG. 4. Localization HA1-p-galactosidase indirect immunofluorescence. Tetraploid yeast cells containing HA1-p-galactosidase
fusion protein (MS157) stained HAl-specific antibody described legend Fig. 3. exposure time 25 s used immunofluorescence micrograph. Bar, 5 p.m.

work shown 0-galactosidase expressed yeast cells            like spt6 mutations (25), nucleosome depletion restores distributed cytoplasm nucleus (13).           mRNA expression alleles upstream activation constructed HAJ-lacZ hybrid gene control             sequence deletions. ADH1 promoter. construct cloning                 approach taking determine function 1.5-kb BamHI-SalI fragment pAD5, contains               SPT6 identify genes encoding proteins func-
ADH1 promoter HAl epitope-coding sequences (gift               tionally related SPT6. SPT6 essential gene, J. Field, L. Rogers, M. Wigler), YEp353,             conceivable mutations functionally related genes
contains coding region E. coli lacZ (24), create             cause lethality combined temperature-
pMS35, used transform yeast cells.                   sensitive spt6 mutations. candidate genes SPT4 Immunofluorescence experiments demonstrated                   SPT5, identified genetic selections HA1-,-galactosidase fusion protein located              extragenic suppressors Ty insertion mutations (11, 32).
yeast cells (Fig. 4). control experiment, staining           combination missense mutations detected strain did contain epitope-             spt4-3, sptS-194, spt6-140 causes lethality (32). 
tagged P-galactosidase fusion protein (data shown).             combinations spt4, sptS, spt6 alleles
observation HAl epitope did direct ,B-galactosi-          exhibit unlinked noncomplementation (M. S. Swanson dase nucleus consistent fact HAl           F. Winston, unpublished observations), phenotype ob-
amino acid sequence (YPYDVPDYA) does resemble                      served mutations proteins known known nuclear signal sequences (9) observation            interact (15, 31). genetic molecular analysis genes addition epitope adenylate cyclase, plasma            appear functionally related SPT6, SPT4,
membrane-associated protein, did alter function             SPT5, histone genes, hope elucidate role enzyme vivo (12).                                              SPT6 gene expression yeast.
   amino terminus predicted SPT6 protein 
cluded regions serve nuclear localization              thank John Celenza advice assistance sequencing
signals  reference 9 review): KLVPR (residues 8             SPT6 gene preparation TrpE-SPT6 antigen 12), KKRRKHKRR (residues 77 85), KRLKRV                         antiserum Laura Davis Linda Marshall-Carlson helpful
(residues 120 125). actual role regions       suggestions regarding immunofluorescence methods. determined experimentally, variety                 work supported Public Health Service grants
                                                                       GM34095 M.C. GM32967 F.W. National Insti-
primary sequences shown function nuclear               tutes Health (NIH). Columbia University, M.S. supported
localization signals (9).                                              NIH training grant T32-GM07088 Department Genetics
   Nuclear localization SPT6 protein consistent         Development. Harvard Medical School, M.S. supported spt6 mutant phenotypes characterized previously. Ge-               NIH training grants Cellular Developmental Biology
netic analysis demonstrated SPT6 affects transcrip-           Program (T32-GM07226) Genetics Program (T32-GM07196)
tion variety genes suggested SPT6 protein         Markey Charitable Trust. act negatively downstream promoter element (8,                                        LITERATURE CITED
25). SPT6 protein interact directly DNA                  1. Bhown,  S., J. C. Bennett. 1983. High-sensitivity se-
previously unidentified DNA-binding motif. Alternatively,                  quence analysis proteins recovered sodium dodecyl
SPT6 protein play role chromatin assembly                      sulfate gels. Methods Enzymol. 91:450-455.
modification. studies correlated alterations               2. Blumenthal, D. K.,  Edelman, E. G. Krebs. 1987. Protein
chromatin structure transcriptional activation                 serine/threonine kinases. Annu. Rev. Biochem. 56:567-613.
views, references 22 29). Like SPT6, proteins                   3. Boyer, H. W., D. Roulland-Dussoix. 1969. complementa-
believed interact chromatin extremely acidic                  tion analysis restriction modification DNA E.
regions (10). Furthermore, SPT6 gene dosage effects                coli. J. Mol. Biol. 41:458-472.
similar caused histone genes. increased           4. Celenza, J. L., M. Carlson. 1986. yeast gene                                                                            essential release glucose repression encodes protein
decreased dosage histone genes suppresses 8                   kinase. Science 233:1175-1180.
insertion mutations (5) deletions SUC2 upstream              5. Clark-Adams, C. D., D. Norris, M.  Osley, J. S. Fassler, regulatory region (J. Hirschhorn F. Winston, unpub-                    F. Winston. 1988. Changes histone gene dosage alter tran-
lished observations). Han Grunstein (14) shown                    scription yeast. Genes Dev. 2:150-159.
 VOL. 10, 1990                                                                                                                 NOTES         4941

 6. Clark-Adams, C. D., F. Winston. 1987. SPT6 gene                 foot mouth disease: responses cattle swine. Science
    essential growth required b-medicated transcrip-            214:1125-1129.
    tion Saccharomyces cerevisiae. Mol. Cell. Biol. 7:679-686.        20.   Kuenzel, E. , J.  Mulligan, J. Sommercorn, E. G. Krebs.
 7. Denis, C. L. 1984. Identification new genes involved             1987. Substrate specificity determinants casein kinase II     regulation yeast alcohol dehydrogenase II. Genetics 108:845-            deduced studies synthetic peptides. J. Biol. Chem.
    858.                                                                       262:9136-9140.
 8. Denis, C. L., T. Malvar. 1990. CCR4 gene                21.   Ma, J., M. Ptashne. 1987. Deletion analysis GAL4 defines
    Saccharomyces cerevisiae required nonfermentative              transcriptional activating segments. Cell 48:847-853.
    spt-mediated gene expression. Genetics 124:283-291.              22.   Mathis, D., P. Oudet, P. Chambon. 1980. Structure  9. Dingwall, C., R.  Laskey. 1986. Protein import              transcribing chromatin. Prog. Nucleic Acids Res. Mol. Biol.
    cell nucleus. Annu. Rev. Cell Biol. 2:367-390.                             24:1-55.
10. Earnshaw, W. C. 1987. Anionic regions nuclear proteins. J.        23.   Munro, S., H. R. B. Pelham. 1987. C-terminal signal
    Cell Biol. 105:1479-1482.                                                  prevents secretion luminal ER proteins. Cell 48:899-907.
11. Fassler, J. S., F. Winston. 1988. Isolation analysis    24.   Myers,  M.,  Tzagoloff, D. M. Kinney, C. J. Lusty. 1986.
    novel class suppressor Ty insertion mutations Saccha-             Yeast shuttle integrative vectors multiple cloning sites
    romyces cerevisiae. Genetics 118:203-212.                                  suitable construction lacZ fusions. Gene 45:299-310.
12. Field, J., J.  Nikawa, D. Broek, B. MacDonald, L. Rodgers,         25.   Neigeborn, L., J. L. Celenza, M. Carlson. 1987. SSN20       Wilson, R.  Lerner, M. Wigler. 1988. Purification           essential gene mutant alleles suppress defects SUC2
    RAS-responsive adenylyl cyclase complex Saccharomy-                 transcription Saccharomyces cerevisiae. Mol. Cell. Biol.
    ces cerevisiae use epitope addition method. Mol. Cell.            7:672-678.
    Biol. 8:2159-2165.                                                   26.   Neigeborn, L., K. Rubin, M. Carlson. 1986. Suppressors 13. Hall, M. N., L. Hereford,  Herskowitz. 1984. Targeting            snJ2 mutations restore invertase derepression cause tem-
    E. coli P-galactosidase nucleus yeast. Cell 36:1057-             perature-sensitive lethality yeast. Genetics 112:741-753.
    1065.                                                                27.   Niman, H. L., R.  Houghten, L. E. Walker, R.  Reisfeld,
14. Han, M., M. Grunstein. 1988. Nucleosome loss activates                   Wilson, J. M. Hogle, R.  Lerner. 1983. Generation     yeast downstream promoters vivo. Cell 55:1137-1145.                     protein-reactive antibodies short peptides event high
15. Hayes, T. S., R. Deuring, B. Robertson, M. Prout, M. T.                frequency